IBJNews

Lilly to pay Utah $24 million to settle Zyprexa suit

Back to TopCommentsE-mailPrintBookmark and Share

Eli Lilly and Co. has agreed to pay Utah $24 million to settle a lawsuit claiming the company improperly marketed the antipsychotic drug Zyprexa, the state's attorney general told Bloomberg News on Wednesday.

Utah sued Lilly in 2007, seeking reimbursement for money spent in the state’s Medicaid program on Zyprexa prescriptions. The state claimed Lilly promoted Zyprexa, approved for schizophrenia and bipolar disorder, for unapproved purposes, Bloomberg said.

The settlement is the latest in a string of legal challenges involving Lilly’s best-selling drug. Zyprexa, which boasts $4.7 billion in annual sales, has sparked thousands of patient lawsuits as well as investigations by federal and state governments.

In January, Lilly agreed to pay $1.42 billion to federal and state governments to resolve a lawsuit over Zyprexa marketing brought by the U.S. Justice Department. Some states, including Utah, Idaho and South Carolina, did not join that settlement.

Last month, Lilly reached a tentative settlement with South Carolina, in which terms have yet to be disclosed. Idaho is getting $13 million as part of its settlement, also reached in October.

 

ADVERTISEMENT

  • Lilly
    Some one better stop this out flow of future payments.Lilly i now end your world ethics programs,You are on, if you except the pledge to move back away from your core beleilf that any drug is better than no drug,to that of an old despart man trying to ease the pain of the Villis conditions of the battle twarn vets of the cival war, by grinding and making help.. Don.. i am not that important.. Harris Ethics officer i/c planet earth
  • Lilly
    How much money, how many law suits, does Lilly settle each year? What percent of my drug cost is budgeted for legal settlements and lawyer fees?

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT